Transgender and gender-diverse youth: an update on standard medical treatments for gender dysphoria and the sociopolitical climate.


Journal

Current opinion in pediatrics
ISSN: 1531-698X
Titre abrégé: Curr Opin Pediatr
Pays: United States
ID NLM: 9000850

Informations de publication

Date de publication:
01 08 2023
Historique:
medline: 7 7 2023
pubmed: 25 4 2023
entrez: 25 4 2023
Statut: ppublish

Résumé

Transgender and gender-diverse (TGD) youth experience a discordance between their binary sex assigned at birth and gender identity. All TGD youth benefit from compassionate care delivered by clinicians who are informed in matters of gender diversity. Some of TGD youth experience clinically significant distress, termed gender dysphoria (GD), and may benefit from additional psychological support and medical treatments. Discrimination and stigma fuel minority stress in TGD youth and thus many struggle with mental health and psychosocial functioning. This review summarizes the current state of research on TGD youth and essential medical treatments for gender dysphoria. These concepts are highly relevant in the current sociopolitical climate. Pediatric providers of all disciplines are stakeholders in the care of TGD youth and should be aware of updates in this field. Children who express gender-diverse identities continue to express these identities into adolescence. Medical treatments for GD have a positive effect on mental health, suicidality, psychosocial functioning, and body satisfaction. The overwhelming majority of TGD youth with gender dysphoria who receive medical aspects of gender affirming care continue these treatments into early adulthood. Political targeting and legal interference into social inclusion for TGD youth and medical treatments for GD are rooted in scientific misinformation and have negative impacts on their well being. All youth-serving health professionals are likely to care for TGD youth. To provide optimal care, these professionals should remain apprised of best practices and understand basic principles of medical treatments for GD.

Identifiants

pubmed: 37097294
doi: 10.1097/MOP.0000000000001256
pii: 00008480-202308000-00006
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

423-429

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Références

Rafferty J. Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents. Pediatrics 2018; 142:
Delozier AM, Kamody RC, Rodgers S, Chen D. Health disparities in transgender and gender expansive adolescents: a topical review from a minority stress framework. J Pediatr Psychol 2020; 45:842–847.
Kuper LE, Stewart S, Preston S, et al. Body dissatisfaction and mental health outcomes of youth on gender-affirming hormone therapy. Pediatrics 2020; 145:1.
Chen D, Berona J, Chan Y, et al. Psychosocial functioning in transgender youth after 2 years of hormones. N Engl J Med 2023; 388:240–250.
American Psychiatric Association Publishing, American Psychiatric Association. The diagnostic and statistical manual of mental disorders, text revision. 5th ed. 2022.
World Health Organization. International statistical classification of diseases and related health problems. 11th ed.; 2019.
Beischel WJ, Gauvin SEM, van Anders SM. A little shiny gender breakthrough’: Community understandings of gender euphoria. Int J Transgender Health 2021; 23:1–21.
Johns MM, Lowry R, Andrzejewski J, et al. Transgender identity and experiences of violence victimization, substance use, suicide risk, and sexual risk behaviors among high school students — 19 states and large urban school districts, 2017. MMWR Morb Mortal Wkly Rep 2019; 68:67–71.
Kidd KM, Sequeira GM, Mann MJ, et al. The prevalence of gender-diverse youth in a rural Appalachian region. Arch Pediatr Adolesc Med 2022; 176:1149–1150.
Kidd KM, Sequeira GM, Douglas C, et al. Prevalence of gender-diverse youth in an urban school district. Pediatrics 2021; 147:e2020049823.
Olson KR, Durwood L, Horton R, et al. Gender identity 5 years after social transition. Pediatrics 2022; 150:1.
Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 2022; 23: (Suppl 1): S1–S259.
Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. Endocr Pract 2017; 102:3869–3903.
Tordoff DM, Wanta JW, Collin A, et al. Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care. JAMA Netw Open 2022; 5:e220978.
Costa R, Dunsford M, Skagerberg E, et al. Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria. J Sex Med 2015; 12:2206–2214.
Turban JL, King D, Carswell JM, Keuroghlian AS. Pubertal suppression for transgender youth and risk of suicidal ideation. Pediatrics 2020; 145:1.
van der Miesen AIR, Steensma TD, de Vries ALC, et al. Psychological functioning in transgender adolescents before and after gender-affirmative care compared with cisgender general population peers. J Adolesc Health 2020; 66:699–704.
van der Loos MATC, Hannema SE, Klink DT, et al. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands. Lancet Child Adolesc Health 2022; 6:869–875.
Turban JL, Dolotina B, King D, Keuroghlian AS. Sex assigned at birth ratio among transgender and gender diverse adolescents in the United States. Pediatrics 2022; 150:e2022056567.
Green AE, DeChants JP, Price MN, Davis CK. Association of gender-affirming hormone therapy with depression, thoughts of suicide, and attempted suicide among transgender and nonbinary youth. J Adolesc Health 2022; 70:643–649.
Hisle-Gorman E, Schvey NA, Adirim TA, et al. Mental healthcare utilization of transgender youth before and after affirming treatment. J Sex Med 2021; 18:1444–1454.
Number of referrals to GIDS. Available at: https://gids.nhs.uk/about-us/number-of-referrals/ [Accessed 2 March 2023].
Puckett JA, Cleary P, Rossman K, et al. Barriers to gender-affirming care for transgender and gender nonconforming individuals. Sex Res Soc Policy 2018; 15:48–59.
Dahlgren Allen S, Tollit MA, McDougall R, et al. A waitlist intervention for transgender young people and psychosocial outcomes. Pediatrics 2021; 148:1.
van der Miesen AIR, Raaijmakers D, van de Grift TC. You have to wait a little longer’: transgender (mental) health at risk as a consequence of deferring gender-affirming treatments during COVID-19. Arch Sex Behav 2020; 49:1395–1399.
Wall CSJ, Patev AJ, Benotsch EG. Trans broken arm syndrome: a mixed-methods exploration of gender-related medical misattribution and invasive questioning. Soc Sci Med 2023; 320:115748.
Parker LL, Harriger JA. Eating disorders and disordered eating behaviors in the LGBT population: a review of the literature. J Eat Disord 2020; 8:51.
Curtis KM, Tepper NK, Jatlaoui TC, et al. U. S. medical eligibility criteria for contraceptive use, 2016. MMWR Recommend Rep 2016; 65:1–103.
Grimstad F, Kremen J, Shim J, et al. Breakthrough bleeding in transgender and gender diverse adolescents and young adults on long-term testosterone. J Pediatr Adolesc Gynecol 2021; 34:706–716.
Carmichael P, Butler G, Masic U, et al. Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK. PLoS One 2021; 16:e0243894.
Giordano S, Holm S. Is puberty delaying treatment ‘experimental treatment’? Int J Transgend Health 2020; 21:113–121.
Giacomelli G, Meriggiola MC. Bone health in transgender people: a narrative review. Ther Adv Endocrinol Metab 2022; 13: 20420188221099346.
Verroken C, Collet S, Lapauw B, T'Sjoen G. Osteoporosis and bone health in transgender individuals. Calcif Tissue Int 2022; 110:615–623.
Schwartz AR, Moravek MB. Reproductive potential and fertility preservation in transgender and nonbinary individuals. Curr Opin Obstet Gynecol 2021; 33:327–334.
Jarrett BA, Corbet AL, Gardner IH, et al. Chest binding and care seeking among transmasculine adults: a cross-sectional study. Transgend Health 2018; 3:170–178.
Cuccolo N, Kang C, Boskey E, et al. Mastectomy in transgender and cisgender patients: a comparative analysis of epidemiology and postoperative outcomes. Plast Reconstr Surg Global Open 2019; 7:e2316.
Hughes LD, Dowshen N, Kidd KM, et al. Pediatric provider perspectives on laws and policies impacting sports participation for transgender youth. LGBT Health 2022; 9:247–253.
Kidd KM, Sequeira GM, Paglisotti T, et al. This could mean death for my child’: parent perspectives on laws banning gender-affirming care for transgender adolescents. J Adolesc Health 2021; 68:1082–1088.
McNamara M, Lepore C, Alstott A, et al. Scientific misinformation and gender affirming care: tools for providers on the front lines. J Adolesc Health 2022; 71:251–253.
Nolan S, Kimball M. A Truth sandwich to inoculate against vaccine misinformation. Psychol Today 2020.

Auteurs

Jacob C Arnold (JC)

Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH